LIVING WITH IT WORKING WITH IT TREATING IT
L’Aspergillose est un terme qui regroupe les infections causées par des champignons appartenant au genre Aspergillus, dont les spores sont véhiculées par l’air et sont inhalées par tous les individus. Totalement inoffensif pour la majorité de la population, ces champignons peuvent cependant provoquer différentes formes de mycoses. L’espèce Aspergillus fumigatus est responsable de plus de 80% des aspergilloses humaines.
The Manchester Fungal Infection Group (MFIG) is a new international centre of excellence for fungal infection biology and translational antifungal research at the University of Manchester. It is integrating its research with that of clinicians and industry.
To understand and reduce the burden of human fungal diseases
With an estimated 1.5 million species, Fungi represent one of the largest branches of the Tree of Life. They have an enormous impact on human affairs and ecosystem functioning, owing to their diverse activities as decomposers, pathogens, and mutualistic symbionts. And perhaps more than any other group of nonphotosynthetic organisms, fungi are essential biological components of the global carbon cycle. Collectively, they are capable of degrading almost any naturally occurring biopolymer and numerous human-made ones. As such, fungi hold considerable promise in the development of alternative fuels, carbon sequestration and bioremediation of contaminated ecosystems.
The use of fungi for the continued benefit of humankind, however, requires an accurate understanding of how they interact in natural and synthetic communities. The ability to sample environments for complex fungal metagenomes is rapidly becoming a reality and will play an important part in harnessing fungi for industrial, energy and climate management purposes. However, our ability to accurately analyze these data relies on well-characterized, foundational reference data of fungal genomes.
To bridge this gap in our understanding of fungal diversity, an international research team in collaboration with the Joint Genome Institute of the Department of Energy has embarked on a five-year project to sequence 1000 fungal genomes from across the Fungal Tree of Life.
A company supporting microbiology & infectious diseases research by providing access to reagents & cultures.
The Protein Data Bank (PDB) archive is the single worldwide repository of information about the 3D structures of large biological molecules, including proteins and nucleic acids. These are the molecules of life that are found in all organisms including bacteria, yeast, plants, flies, other animals, and humans. Understanding the shape of a molecule deduce a structure's role in human health and disease, and in drug development. The structures in the archive range from tiny proteins and bits of DNA to complex molecular machines like the ribosome.
A tool for the layperson to make sense of health studies: Trying to make sense of health research?
This tool will guide you through a series of questions to help you to review and interpret a published health research paper.
CDC's lead group for the prevention and control of fungal infections in the United States and internationally through epidemiological and microbiological studies to improve the diagnosis, treatment, prevention, and control of mycotic diseases.
CDC's Mycotic Disease Branch (MDB) is dedicated to preventing death and disability due to fungal diseases. As one of the only public health groups in the world devoted specifically to the prevention and control of fungal infections, MDB works with domestic and international partners to determine the burden of fungal infections, respond to outbreaks, and to address public health problems related to fungal infections. Fungal diseases are a concern in the medical and public health community for several reasons[PDF - 2 pages]:
Our Branch is composed of three teams. Epidemiology and laboratory staff members work together to generate new information about the burden of fungal diseases and disease-causing fungi, detect and identify fungi in clinical samples, investigate the source of fungal outbreaks, conduct applied public health research, and provide training in the identification of medically important fungi.
Just like antibiotics cure bacterial infections, antifungal medications save lives by curing dangerous fungal infections. And just like some bacterial infections are resistant to antibiotics, some fungi no longer respond to the antifungal medications that are designed to cure them. This emerging phenomenon is known as antifungal resistance, and it’s primarily a concern for invasive infections with the fungus Candida but also Aspergillus.
Although antibiotic-resistant bacterial infections are a widely-recognized public health threat, less is known about the effects of antifungal resistance and the burden of drug-resistant fungal infections. This highlights the need for an improved understanding of the reasons for their emergence, heightened awareness among medical and public health communities about these infections, and greater attention to methods that can be used to prevent and control them.
Laboratory of pathogenic fungi has been created as part of the Research Institute of Medical Mycology. PN Kashkina GOU DPO MAPS Medical University as "a central collection of pathogenic fungi of the Russian Federation" Order of the RF Ministry of Health of 28.01.2004, № 19 "On establishment of the Russian collection of pathogenic fungi Ministry of Health of Russia" (with the "Regulations on the Russian collection of pathogenic fungi (RKPG)") . In 2014, the laboratory was renamed in Laboratory "Russian collection of pathogenic fungi" Research Institute of Medical Mycology. PN Kashkina SZGMU Medical University them. II Mechnikov Russian Ministry of Health.
Find out more Fungi are everywhere, and a few species can cause very serious lethal infections. Fungal infections (mycoses) kill more people around the world than malaria. There are no vaccines to protect against fungal infections and we often diagnose them too late to save the patient. Our exhibit spotlights UK research that will help to improve prevention, diagnosis and treatment of mycoses. Across the UK, teams of scientists and doctors are working together to address the huge unmet need for better treatment of fungal infections. We now understand how fungi are recognised by our immune system; paving the way for treatments to boost immune effectiveness, or dampen the damaging inflammation caused by fungal infection. Designing fungus-specific antibiotics is challenging because fungi share many genetic properties with us. However, new drugs may selectively target features of fungi, such as the cell wall. And antibodies are being developed that can be used either for treatment or to assist in early diagnosis. This research is helping to inform and improve clinical options in the worldwide fight against fungal diseases.
Watch video here
Aimed at Schools Key Stage 2, this website introduces fungi and other micro-organisms to young children
Hello, I'm Dr David Moore and I am a mycologist at the University of Manchester.
Well, let me explain, a mycologist is someone who has studied, and therefore knows quite a lot about fungus. The fungus Kingdom includes mushrooms and yeast and much, much more. As a mycologist, I know the common (Penny Bun) and Latin (Boletus edulis) names of many species of fungi, but more than 100,000 species exist, so I learn more every day! I know how they are classified; what they look like; how they reproduce, feed and grow; how they are used to make medicines (like penicillin and statins) and food (beer, wine, cheese, edible mushrooms, Quorn) and also their dangers such as poisoning and infection. As you can see, mycology is an extremely fascinating and important subject.